Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
Resource Type
Article
Authors
Hurvitz, Sara A ; Hegg, Roberto ; Chung, Wei-Pang ; Im, Seock-Ah ; Jacot, William ; Ganju, Vinod ; Chiu, Joanne Wing Yan ; Xu, Binghe ; Hamilton, Erika ; Madhusudan, Srinivasan ; Iwata, Hiroji ; Altintas, Sevilay ; Henning, Jan-Willem ; Curigliano, Giuseppe ; Perez-Garcia, José Manuel ; Kim, Sung-Bae ; Petry, Vanessa ; Huang, Chiun-Sheng ; Li, Wei ; Frenel, Jean-Sebastien ; Antolin, Silvia ; Yeo, Winnie ; Bianchini, Giampaolo ; Loi, Sherene ; Tsurutani, Junji ; Egorov, Anton ; Liu, Yali ; Cathcart, Jillian ; Ashfaque, Shahid ; Cortés, Javier
Source
In The Lancet 14-20 January 2023 401(10371):105-117
Subject
Primary Research Articles
Language
ISSN
0140-6736